Most Recent
Fair Work Ombudsman wins appeal over CFMEU penalty in Hutchison Ports strike case
An appeals court has handed a win to the Fair Work Ombudsman in its battle for a multimillion dollar penalty against the CFMEU for coordinated strikes at two Hutchison Ports shipping terminals, finding a judge's fine of just $38,000 did not cut it.
IOOF chair told APRA conflicts of interest were ‘a bit of a non-event’
The former chairman of troubled IOOF told APRA during a review meeting that he "struggled" to think the wealth manager had any conflicts of interest and that the issue was getting too much "airplay", according to court documents filed recently by the prudential regulator.
Sandoz entitled to generic Lexapro licence, IP Australia finds in blow to Lundbeck
Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.
Lundbeck sues IP Australia, Sandoz to escape undertaking over Lexapro licence
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court's decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.
Judge ‘uncomfortable’ with common fund order in toxic foam class actions
A judge overseeing three toxic foam class actions against the Commonwealth of Australia has said he's not comfortable approving a common fund order which does not detail specific remuneration amounts for funder IMF Bentham.
Deep Investments can’t take another shot at case, Full Court says
The Full Court has denied a bid by Deep Investments to vary orders dismissing its case against a solicitor and six others over $10 million in alleged share trading losses, saying this would amount to allowing the investment adviser to bring a different claim.
Sandoz wins stay of $26.3M Lexapro judgment
Generic pharmaceutical firm Sandoz has won a temporary stay of a $26.3 million judgment in a patent case as it awaits a decision by the Commissioner of Patents regarding a licence to make a cheaper version of the bestselling antidepressant Lexapro.
Class action trial against WorleyParsons back on as new judge steps in
Trial in a shareholder class action against engineering company WorleyParsons will be heard by a new judge in late August, six months after it was unexpectedly vacated.
Liquidator loses appeal to block evidence as ATO aims at 10 year ban
An appeals court has dismissed a challenge by Veritas Advisory principal liquidator David Iannuzzi to the admissibility of evidence submitted by the Australian Taxation Office in the agency's case seeking compensation and a 10-year ban.
CIMIC slugged with costs after class action trial vacated
Global engineering firm CIMIC Group has been hit with costs after a last-minute subpoena of three new potential witnesses caused the three-week trial that was due to commence later this month to be vacated.